Net Cash Provided by (Used in) Investing Activities of REVELATION BIOSCIENCES, INC. from 31 Dec 2020 to 31 Dec 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.
Summary
REVELATION BIOSCIENCES, INC. annual and quarterly Net Cash Provided by (Used in) Investing Activities in USD history and change rate from 31 Dec 2020 to 31 Dec 2024.
  • REVELATION BIOSCIENCES, INC. Net Cash Provided by (Used in) Investing Activities for the quarter ending 31 Mar 2024 was $19,172.
  • REVELATION BIOSCIENCES, INC. annual Net Cash Provided by (Used in) Investing Activities for 2024 was $19,171.
  • REVELATION BIOSCIENCES, INC. annual Net Cash Provided by (Used in) Investing Activities for 2021 was $131,963.
Source SEC data
View on sec.gov
Net Cash Provided by (Used in) Investing Activities, Annual (USD)
Net Cash Provided by (Used in) Investing Activities, Quarterly (USD)

REVELATION BIOSCIENCES, INC. Annual Net Cash Provided by (Used in) Investing Activities (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2024 $19,171 01 Jan 2024 31 Dec 2024 10-K 26 Feb 2026 2025 FY
2021 $131,963 +$73,904,362 01 Jan 2021 31 Dec 2021 10-K 30 Mar 2023 2022 FY
2020 $74,036,325* 01 Jan 2020 31 Dec 2020 10-K 15 Apr 2022 2021 FY

REVELATION BIOSCIENCES, INC. Quarterly Net Cash Provided by (Used in) Investing Activities (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q1 2024 $19,172 -$19,172 01 Jan 2024 31 Mar 2024 10-Q 08 May 2025 2025 Q1
Q1 2023 $0 01 Jan 2023 31 Mar 2023 10-Q/A 23 Sep 2024 2024 Q1
Q1 2021 $99,101 01 Jan 2021 31 Mar 2021 10-Q 16 May 2022 2022 Q1
* An asterisk sign (*) next to the value indicates that the value is likely invalid.